HOTH: hoththerapeutics.com Cash Calculated per Single Share

Hoth Therapeutics - graphic logo of issuer HOTH

Hoth Therapeutics, Inc. (HOTH) is developing advanced drug delivery systems to combat cancer and psoriasis, relying on future insurance reimbursements. Cash per share for the period reflects this strategy, with the current mark standing at 0.21. The company is currently executing a planned burn of existing capital to fund intensive R&D in the absence of operating revenue.

Hoth Therapeutics Inc. (HOTH) - Cash per Share from 07/04/2022 to 05/28/2026

Comprehensive metric breakdowns and analytics for Hoth (HOTH)

- cash availability and cash flow indicators:
Comprehensive company analysis:Hoth Therapeutics (HOTH)
Flagship merchandise of Hoth Therapeutics Inc.

The indicator's dynamics depend directly on quarterly reporting of cash balances and the volume of share issuance. This metric determines the share of net liquid assets per security. For Hoth Therapeutics, Inc. (HOTH), this reserve is critical when conducting costly clinical trials in the US. The absence of sanctions risks stabilizes financial planning. By analyzing the current level of liquidity per share, an investor assesses the stability of the company's capital.